The World's Greatest Investing Community
Results 1 - 10 of 83 : 1 2 3 4 5 6 7 8 9 Next
Investing 101: Biotech Stocks With Insider Buying
If anyone knows what's going on with a company, it has to be the people who work there.
Are Supply Troubles a Biotech Buying Opportunity?
Running production close to demand trips up ViroPharma.
ViroPharma Misses on Both Revenue and Earnings
Just the facts, Fool.
Why ViroPharma Shares Got Pummeled
Is this meaningful or just another movement?
Something to Watch at ViroPharma
These two metrics can tell you a lot.
5 of Last Week's Biggest Losers
These five stocks only made shorts some serious money last week.
The Week's Biggest Stock Disappointments
The market lost some ground this week, and some stocks took serious plunges.
With Revenue Decimated, Is ViroPharma a Buy?
ViroPharma is easier to value.
Why Did These Stocks Just Die?
These stocks just rolled over. Can they come back?
Why ViroPharma Shares Imploded
Is this meaningful or just another movement?
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK